Our mission is to transform individual lives and fundamentally change the way diseases are managed, interpreted, and prevented. We believe that challenging something is the best way to change it.
If you are interested in becoming a Corporate Sponsor for our 2022 Annual Meeting, or for more information on the Sponsorship options available, please download the prospectus here or contact us at email@example.com.
Thank You to Our 2021 Corporate Sponsors!
Frontier Science Foundation is a not-for-profit research organization dedicated to the improvement of data management and statistical quality in clinical trials and medical research.
The GW Biostatistics Center has a 47 year history of leadership in practice-changing clinical trials and biostatistical methodology research. Center research has been recognized in reports to the US President and Congress and resulted in over 60 NEJM publications.
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.
Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, Bayesian analysis, adaptive clinical trial execution, and simulation software solutions for the pharmaceutical and medical device industry.
Emmes collaborates with clients to produce valued, trusted scientific research. We are passionate about making a difference in the quality of human health, and have supported more than a thousand studies across a diverse range of diseases since our formation in 1977.
The Jaeb Center for Health Research was established in 1993 as a freestanding, nonprofit coordinating center for multi-center clinical trials and epidemiologic research. The Jaeb Center's focus is eye disorders or type 1 diabetes.
The Oxford Recovery Model develops a targeted healing approach for each unique patient. We employ numerous therapies and healing modalities to treat a wide range of conditions.
The Data Coordinating Center (DCC) is a component of the Clinical Trials Program in the Department of Biostatistics and Medical Informatics at the UW School of Medicine and Public Health. The DCC supports investigator-initiated NIH or industry-sponsored RCTs. We provide expertise in planning, conduct, monitoring, and analysis of clinical trials.
Xeris Pharmaceuticals is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. XeriSol™ and XeriJect™ can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system. Learn more at www.xerispharma.com
At KONTEKST we have been providing our clients with highly-specialized translations for the clinical research, medical, pharmaceutical, legal, and financial industry for over 20 years. We deliver expert translations in 250 language combinations. KONTEKST is committed to constant improvement, innovation and growth to cooperate with international clients.
Statistics Collaborative is dedicated to developing research programs with scientific rigor and statistical validity. For more than 30 years, our clients have relied on us for careful thought, meticulous attention to detail, and expertise across a range of statistical methods and therapeutic areas.